According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal ...

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

The following is a summary of “Prevalence of Mast Cell Activation Disorders and Hereditary Alpha Tryptasemia Amongst POTS and ...

Joan Smith spent almost 40 years believing she suffered from severe allergies. Medical professionals frequently dismissed her ...